FDA Inspection
Neurocrine Biosciences IncNeurocrine Biosciences Inc – FDA Inspection, Jul 18, 2024
Record Details
This FDA Inspection record concerns Neurocrine Biosciences Inc, with an inspection on July 18, 2024, issued by the Center for Drug Evaluation and Research.
- Company
- Neurocrine Biosciences Inc
- Inspection Date
- July 18, 2024
View Company Profile
ID · d7a6a21a-b605-42d6-8f34-1c4aee5aa3ff
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1244087
- FDA center
- Human Drugs
- Project area
- Postmarket Surv. and Epidemiology
FDA Citations
1- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Neurocrine Biosciences Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 2, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Neurocrine Biosciences Inc
- FDA Inspection 998843 - 2016-12-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.